Moving out from single-channel communication to opti-channel marketing will expand the reach of pharmaceutical brands, connect them to the physicians and also help them judge their performance in the market. We have created a category of programmatic physician marketing by initially enabling pharma brands to reach out to physicians via display and text-based messaging, the company said in a statement.
With this new platform, the company believes that it can help pharma brands to showcase a single message to physicians on multi channels – display email and SMS, pronouncing greatly the impact of digital messaging campaigns. Additionally, the real-time dashboard is set to provide insights into the performance of the company’s channel increasing the transparency and assisting companies to judge the overall performance of their campaign.
Talking about the digital changes that the pharma sector needs to adapt to, Dr. Harshit Jain, Founder and Global CEO, Doceree, said,“While there is considerable openness among brands now towards the medium, there is still a lot that needs to be achieved to incline pharma towards innovative digital technologies. The pandemic did change the way the pharma industry perceived digital. But now we have moved beyond that stage to address peculiar issues that are crippling penetration of digital in the industry.”
“We are developing capabilities that would make digital a crucial marketing component for the pharma industry. It is thus important that we enable pharma brands to gain access to physicians’ touchpoints across effective digital channels. That’s what our product is aiming to establish while allowing pharma brands to have complete transparency on digital messaging campaigns.” he added.
The company said that it is aiming to improve overall business outcomes of pharma brands on digital platforms with its latest opti-channel marketing approach. It is also trying to democratize the pharma sector by enabling marketers to have tactical insights around a physician’s behaviour and engagement levels.